RNS Number : 3109K
  York Pharma plc
  17 December 2008
   



 TR-1: Notifications of Major Interests in Shares

 1. Identity of the issuer or the underlying issuer
 of existing shares to which voting rights are
 attached:                                             York Pharma plc


 2. Reason for notification (yes/no)

 An acquisition or disposal of voting rights

 An acquisition or disposal of financial instruments which may result in
 the acquisition of shares already issued to which voting rights are
 attached 

 An event changing the breakdown of voting rights
                                                                                      X
 Other (please specify): Dilution due to share capital increase

 3. Full name of person(s)       1. Awal Trust Company Limited (as "parent undertaking" of Awal
 subject to notification         Bank B.S.C. [Awal] and Saad Investments Company Ltd [SICL])
 obligation:

                                 2. Maan Abdulwahed Al-Sanea (as "parent undertaking" of Awal and
                                 SICL)


 4. Full name of shareholder(s)  Vidacos Nominees Pty Ltd. (as nominee for Awal) and
 (if different from 3):

                                 Bear Stearns Securities Corp (as nominee for SICL) 


 5. Date of transaction (and     n/a
 date on which the threshold is
 crossed or reached if
 different):

 6. Date on which issuer         16 December 2008
 notified:

 7. Threshold(s) that is/are     21% threshold was crossed, down to 20%
 crossed or reached:

 8: Notified Details
 A: Voting rights attached to shares

 Class/type of shares       Situation previous to the triggering        Resulting situation after the triggering transaction
 If possible use ISIN code  transaction
                            Number of shares      Number of voting      Number of shares  Number of voting        Percentage of voting
                                                  rights                                  rights                  rights

                                                                                          Direct  Indirect        Direct       Indirect
 GB00B00QHC86               12,367,399            12,367,399            12,367,399        Nil     12,367,399      Nil          20.32%


 B: Financial Instruments

 Resulting situation after the triggering transaction

 Type of financial instrument  Expiration date  Exercise/ conversion  No. of voting rights  Percentage of voting
                                                period/date           that may be acquired  rights
                                                                      (if the instrument
                                                                      exercised/converted)
 -                             -                -                     -                     -



 Total (A+B)

 Number of voting rights  Percentage of voting rights
 12,367,399               20.32%

 9. Chain of controlled undertakings through which the voting rights and /or
 the financial instruments are effectively held, if applicable:
 Maan Abdulwahed Al-Sanea is subject to a notification obligation pursuant to
 DTR 5.2.1(e) as a "parent undertaking" of Awal, the indirect holder of
 8,558,699 shares, and as a "parent undertaking" of SICL, the indirect holder
 of 3,808,700 shares; his joint holding amounts to 20.32%.


 Awal and SICL are indirectly owned by Awal Trust Company Limited ("ATCL") as
 trustee of the Saad STAR Trust. ATCL is therefore subject to notification
 obligation pursuant to DTR 5.2.1(e) as a "parent undertaking" of Awal and
 SICL.

 Proxy Voting:

 10. Name of proxy holder:                                         -

 11. Number of voting rights proxy holder will cease to hold:      -

 12. Date on which proxy holder will cease to hold voting rights:  -


 13. Additional information:     Awal Bank D.S.C. indirectly holds 8,558,699
                                 (14.06%) shares through Vidacos Nominees Pty
                                 Ltd.


                                 Saad Investments Company Limited indirectly
                                 holds 3,808,700 (6.26%) shares through Bear
                                 Stearn Securities Corp.

 14 Contact name:                Christopher C Hart

 15. Contact telephone number :  +41 22 715 0303




This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
HOLBXBDDUBBGGIR

York Pharma (LSE:YRK)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more York Pharma Charts.
York Pharma (LSE:YRK)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more York Pharma Charts.